These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20830538)

  • 21. Different impact of NNRTI and PI-including HAART on bone mineral density loss in HIV-infected patients.
    Madeddu G; Spanu A; Solinas P; Babudieri S; Calia GM; Lovigu C; Mannazzu M; Nuvoli S; Piras B; Bagella P; Mura MS; Madeddu G
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4576-89. PubMed ID: 26698255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone Loss Among Women Living With HIV.
    Weitzmann MN; Ofotokun I; Titanji K; Sharma A; Yin MT
    Curr HIV/AIDS Rep; 2016 Dec; 13(6):367-373. PubMed ID: 27678124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study.
    Prior J; Burdge D; Maan E; Milner R; Hankins C; Klein M; Walmsley S
    Osteoporos Int; 2007 Oct; 18(10):1345-53. PubMed ID: 17665239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Influence of anitiretroviral therapy on bone tissue metabolism in patients with HIV].
    Olczak A; Pawłowska M; Drózdz W
    Przegl Epidemiol; 2008; 62(1):155-62. PubMed ID: 18536239
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiretroviral therapy induces a rapid increase in bone resorption that is positively associated with the magnitude of immune reconstitution in HIV infection.
    Ofotokun I; Titanji K; Vunnava A; Roser-Page S; Vikulina T; Villinger F; Rogers K; Sheth AN; Lahiri CD; Lennox JL; Weitzmann MN
    AIDS; 2016 Jan; 30(3):405-14. PubMed ID: 26760232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The skeleton goes to pot.
    Davenport RJ
    Sci Aging Knowledge Environ; 2005 May; 2005(21):nf39. PubMed ID: 15917506
    [No Abstract]   [Full Text] [Related]  

  • 28. Review of Secondary Causes of Osteoporotic Fractures Due to Diabetes and Spinal Cord Injury.
    Zamarioli A; de Andrade Staut C; Volpon JB
    Curr Osteoporos Rep; 2020 Jun; 18(3):148-156. PubMed ID: 32147752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Single-dose Zoledronic Acid Infusion Prevents Antiretroviral Therapy-induced Bone Loss in Treatment-naive HIV-infected Patients: A Phase IIb Trial.
    Ofotokun I; Titanji K; Lahiri CD; Vunnava A; Foster A; Sanford SE; Sheth AN; Lennox JL; Knezevic A; Ward L; Easley KA; Powers P; Weitzmann MN
    Clin Infect Dis; 2016 Sep; 63(5):663-671. PubMed ID: 27193748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Understanding the mechanisms of senile osteoporosis: new facts for a major geriatric syndrome.
    Duque G; Troen BR
    J Am Geriatr Soc; 2008 May; 56(5):935-41. PubMed ID: 18454751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of bone mineral density in Iranian HIV/AIDS patients.
    Badie BM; Soori T; Kheirandish P; Izadyar S; SeyedAlinagh S; Foroughi M; Rostamian A; Mohraz M
    Acta Med Iran; 2011; 49(7):460-7. PubMed ID: 21960080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of HIV and antiretroviral therapy in bone disease.
    Gutiérrez F; Masiá M
    AIDS Rev; 2011; 13(2):109-18. PubMed ID: 21587342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and risk factors for osteopenia/osteoporosis in an HIV-infected male population.
    Tomazic J; Ul K; Volcansek G; Gorensek S; Pfeifer M; Karner P; Prezelj J; Vidmar G; Vidmar L
    Wien Klin Wochenschr; 2007; 119(21-22):639-46. PubMed ID: 18043884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone mineral abnormalities in persons with HIV infection: signal or noise?
    Singh K; Moyle GJ
    AIDS Read; 2006 Aug; 16(8):407-10, 413-8. PubMed ID: 16933375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulatory mechanisms of osteoblast and osteoclast differentiation.
    Katagiri T; Takahashi N
    Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Osteoporosis and RANKL signal].
    Nakamura M; Udagawa N
    Clin Calcium; 2011 Aug; 21(8):1149-55. PubMed ID: 21814019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002).
    Martin K; Lawson-Ayayi S; Miremont-Salamé G; Blaizeau MJ; Balestre E; Lacoste D; Ragnaud JM; Malvy D; Dupon M; Mercié P; Schaeverbeke T; Haramburu F; Dabis F;
    HIV Med; 2004 Nov; 5(6):421-6. PubMed ID: 15544694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New antiretroviral drugs and approaches to HIV treatment.
    Paredes R; Clotet B
    AIDS; 2003; 17 Suppl 4():S85-96. PubMed ID: 15080184
    [No Abstract]   [Full Text] [Related]  

  • 39. The long-term consequences of antiretroviral therapy: a review.
    Boyd M; Reiss P
    J HIV Ther; 2006 Jun; 11(2):26-35. PubMed ID: 16981593
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV infection--a risk factor for osteoporosis.
    Thomas J; Doherty SM
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):281-91. PubMed ID: 12843738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.